<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">3574</id>
  <title>T3D3532</title>
  <common-name>Salvinorin A </common-name>
  <description>Salvinorin A is the main active psychotropic molecule in Salvia divinorum, a Mexican plant which has a long history of use as an entheogen by indigenous Mazatec shamans. Salvinorin A is a hallucinogenic compound with dissociative effects (L1181).</description>
  <cas>83729-01-5</cas>
  <pubchem-id>128563</pubchem-id>
  <chemical-formula>C23H28O8</chemical-formula>
  <weight>432.178420</weight>
  <appearance>Colorless crystals from methanol (A646).</appearance>
  <melting-point>238-244°C</melting-point>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility></solubility>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure>Ingestion (L1817) ; dermal (L1817)</route-of-exposure>
  <target nil="true"/>
  <mechanism-of-toxicity>Salvinorin A, the active component of the hallucinogenic sage Salvia divinorum, is an apparently selective and highly potent kappa-opioid receptor (KOR) agonist. Salvinorin A is unique among ligands for peptidergic G protein-coupled receptors in being nonnitrogenous and lipid-like in character (A647).</mechanism-of-toxicity>
  <metabolism>Salvinorin A’s chemical structure suggests that it may be a substrate of CYP450 (oxidative metabolism), UGT (hydrolysis) or carboxylesterases (ChEs) (hydrolysis). In addition, as observed for CYP1A1, CPY2C18 and CYP2E1, Salvinorin A metabolism via UGTB27 appears to be saturable at higher concentrations.</metabolism>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity>No indication of carcinogenicity (not listed by IARC). (L135)</carcinogenicity>
  <use-source>Traditional medicine used by the Mazatec people of Oaxaca, Mexico (A646).</use-source>
  <min-risk-level nil="true"/>
  <health-effects>Psychedelic-like changes in visual perception, mood, and body sensations (A645).</health-effects>
  <symptoms>Hallucinations or delusional episodes that mimic psychosis. ; emotional swings; feelings of detachment; and importantly, a highly modified perception of external reality and the self, which leads to a decreased ability to interact with one's surroundings (A645).</symptoms>
  <treatment>Treatment for salvinorin A overdose would be similar to the treatments for hallucinogen intoxication. (A648)</treatment>
  <created-at type="dateTime">2009-07-30T17:59:08Z</created-at>
  <updated-at type="dateTime">2014-12-24T20:26:07Z</updated-at>
  <interacting-proteins>Cytochrome P450 1A1 (CYP1A1) (P04798)  (A332)  Cytochrome P450 2C18 (CYP2C18) (P33260)  (A332)  Cytochrome P450 2E1 (CYP2E1) (P05181)  (A332)</interacting-proteins>
  <wikipedia>http://en.wikipedia.org/wiki/Salvinorin</wikipedia>
  <uniprot-id nil="true"/>
  <kegg-compound-id></kegg-compound-id>
  <omim-id></omim-id>
  <chebi-id></chebi-id>
  <biocyc-id></biocyc-id>
  <ctd-id nil="true"/>
  <stitch-id>Salvinorin A </stitch-id>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins>Cytochrome P450 1A1 (P04798)    
Cytochrome P450 2C18 (P33260)   
Cytochrome P450 2E1 (P05181)  
(A332)</metabolizing-proteins>
  <transporting-proteins nil="true"/>
  <moldb-smiles>COC(=O)C1CC(OC(C)=O)C(=O)C2C1(C)CCC1C(=O)OC(CC21C)C1=COC=C1</moldb-smiles>
  <moldb-formula>C23H28O8</moldb-formula>
  <moldb-inchi>InChI=1S/C23H28O8/c1-12(24)30-16-9-15(20(26)28-4)22(2)7-5-14-21(27)31-17(13-6-8-29-11-13)10-23(14,3)19(22)18(16)25/h6,8,11,14-17,19H,5,7,9-10H2,1-4H3</moldb-inchi>
  <moldb-inchikey>InChIKey=OBSYBRPAKCASQB-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">432.4636</moldb-average-mass>
  <moldb-mono-mass type="decimal">432.178417872</moldb-mono-mass>
  <origin>Exogenous</origin>
  <state>Solid</state>
  <logp nil="true"/>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference></synthesis-reference>
  <structure-image-caption nil="true"/>
</compound>
